Correction Sees Cannabis Stocks Fall

 | Mar 19, 2019 04:08AM ET

Shares in most major Canadian cannabis producers are now undergoing a correction following moderate-to-strong growth in response to Hexo Corp (TO:HEXO) posting better Q2 earnings (up to $16.2 million).

As the company itself acknowledges, it owes a large part of this success to the significant rise in demand within the recreational cannabis sector as a whole. Just a day earlier, it was another positive development for Hexo that helped to buoy the market as the company announced plans to acquire Newstrike Brands Ltd. — a venture backed by former Canadian rock group The Tragically Hip — in a deal worth an estimated CAD 263 million (USD 198 million). Once it completes the acquisition, Hexo will gain close to 2 million square feet of additional production space.

Finally, the market received one last piece of good news this week in the form of Aurora Cannabis's (ACB) announcement that major investor Nelson Peltz had joined the company as a senior advisor.

In conclusion, it is likely that this downward correction will be sustained over the medium-to-short term, as is to be expected after such a sharp rise. With this in mind, we can expect shares in the big Canadian producers to continue on their current trajectory, with Aurora Cannabis Inc (TO:ACB) tipped to fall to $8, Canopy Growth Corp (NYSE:CGC) to $45, Tilray Inc (NASDAQ:TLRY) to $72, Aphria Inc (TO:APHA) to $12 and Cronos Group Inc (NASDAQ:CRON) to $20.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes